AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans
AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans
AstraZeneca will invest US$50bn in the US to expand manufacturing and research
AstraZeneca shares show signs of life after successful trials of hypertension drug
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - CNBC
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year. https://t.co/b5hOwTxWaU https://t.co/Wq5EsZGLK5
AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition
221.9BUSD
taip
Common Stock
Pertukaran
PINK
Kod matawang
USD
Nama Mata Wang
US Dollar
Nama negara
USA
ISO negara
US
ADALAH DALAM
GB0009895292
CUSIP
-
Sektor
Healthcare
industri
Drug Manufacturers - General
Akhir Tahun Fiskal
December
tarikh IPO
-
Dikemaskini Pada
-
Nisbah PE
28.55
Nisbah PEG
0.95
Nilai buku
26.48
Bahagian Dividen
3.1
Hasil Dividen
2.22%
Bahagian Pendapatan
4.97
Harga Sasaran Wall Street
-
Anggaran EPS Tahun Semasa
-
Anggaran EPS Tahun Depan
-
EPS Anggaran Suku Tahun Semasa
0
Anggaran EPS Suku Tahun Seterusnya
0
Suku Terkini
-
Hasil TTM
54,982,000,640
Keuntungan Kasar TTM
45,328,998,400
EBITDA
18,276,999,168
Margin keuntungan
14.14%
Pulangan Atas Aset TTM
8.16%
Pulangan Atas Ekuiti TTM
19.79%
Hasil Sesaham TTM
35.467
Pertumbuhan Hasil Qtly YOY
7.20%
Eps TTM yang dicairkan
4.97
Pertumbuhan Pendapatan Qtly YOY
33.60%
PE mengekori
28.55
PE ke hadapan
15
Harga Jualan TTM
4.0009
Buku Harga MRQ
5.3602
Hasil Nilai Perusahaan
4
EBITDA Nilai Perusahaan
15
70.34
5.35%73.16
3.77%798.84
2.98%190.58
1.96%40.23
1.11%118.03
0.99%168.51
0.36%337.00
0.07%114.52
-3.52%317.30
-1.29%